1. Home
  2. POAS vs RDHL Comparison

POAS vs RDHL Comparison

Compare POAS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

SELL

Current Price

$2.65

Market Cap

2.8M

Sector

Industrials

ML Signal

SELL

RDHL

Redhill Biopharma Ltd.

N/A

Current Price

$0.48

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POAS
RDHL
Founded
2017
2009
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.3M
IPO Year
2024
2012

Fundamental Metrics

Financial Performance
Metric
POAS
RDHL
Price
$2.65
$0.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
161.6K
★ 810.6K
Earning Date
11-21-2026
09-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17,592.31
Revenue Next Year
N/A
$25.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$0.44
52 Week High
$7.40
$2.14

Technical Indicators

Market Signals
Indicator
POAS
RDHL
Relative Strength Index (RSI) 88.31 41.18
Support Level $1.51 $0.44
Resistance Level $2.83 $0.71
Average True Range (ATR) 0.22 0.05
MACD 0.27 0.00
Stochastic Oscillator 82.44 19.52

Price Performance

Historical Comparison
POAS
RDHL

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers high tech microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

About RDHL Redhill Biopharma Ltd.

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

Share on Social Networks: